Evaluation of URO17 to improve non-invasive detection of bladder cancer

CONCLUSION: Limitations include cross-sectional design and convenience sampling. URO17 may improve sensitivity of urine cytology in the detection of urothelial cancer, though further study is required to refine the application of this biomarker in clinical practice.PMID:38553264 | DOI:10.1016/j.urolonc.2024.02.012

Source: Cancer Control - March 29, 2024 Category: Cancer & Oncology Authors: Sima P Porten Elizabeth Y Wang Poonam Vohra Peter R Carroll Sholeh Jahanfard Nam W Kim Source Type: research